Sprint Bioscience
SPRINT | ST
Overview
Corporate Details
- ISIN(s):
- SE0006343745
- LEI:
- 5493006ED74WIIQOKC56
- Country:
- Sweden
- Address:
- C/O NOVUM, 141 57 Huddinge
- Website:
- https://sprintbioscience.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Sprint Bioscience is a pharmaceutical company specializing in early-stage drug development for cancer. The company employs a fragment-based drug discovery platform to efficiently create innovative drug programs. Its business model centers on developing these programs to the preclinical phase and then out-licensing them to global pharmaceutical companies for further clinical development and commercialization. This approach is designed to be time- and resource-efficient, shortening traditional drug development timelines. Founded in 2009, Sprint Bioscience focuses on generating a pipeline of novel drug candidates to address unmet needs in oncology.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Sprint Bioscience.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Automate Your Workflow. Get a real-time feed of all Sprint Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Sprint Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
